1 results match your criteria: "2409 University Ave. Stop A 1930[Affiliation]"
Clin Drug Investig
March 2024
Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, 2409 University Ave. Stop A 1930, Austin, TX, 78712, USA.
Background And Objectives: Two oral calcitonin gene-related peptide (CGRP) antagonists, atogepant and rimegepant, were approved in 2021 for the preventive treatment of episodic migraine (EM), yet no formal cost-effectiveness analysis has been published. The objective of this study was to evaluate the cost-effectiveness of atogepant 60 mg and rimegepant 75 mg compared with placebo.
Methods: A decision tree model was constructed over a 1-year time horizon from a US societal perspective.